Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02083549 · ClinicalTrials.gov registry record
Evaluating URMC's Massive Transfusion Protocol
A clinical trial, sponsored by University of Rochester.
- Completed
- Registry status
- 2
- Enrollment target
NCT02083549: Completed study, sponsored by University of Rochester.
NCT02083549 is a clinical trial that has completed, run by University of Rochester. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02083549 has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- 2 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the efficacy of the University of Rochester Medical Center's current Massive Transfusion Protocol. Upon arrival of trauma level one designated patients the treating team evaluates the patient's injuries. If the patient is initiated under the facilities Massive Transfusion Protocol and meets other inclusion and exclusion criteria the patient will be enrolled in the study. Study procedures include collection of a blood sample following the transfusion of each shipment, through shipment 5, of blood products outlined in the current Massive Transfusion Protocol. Each blood sample will be run on a Thromboelastograph to evaluate the patient's hematostatic state through resuscitation. One final blood sample will be collected 24 hours following the discontinuation of the Massive Transfusion Protocol and also ran on the thromboelastograph. Due to the critical need for medical intervention, consent procedure will be waived at time of enrollment. An authorized representative for the patient will be identified and approached to obtain consent for use of data collected.
Primary Outcome
Through thromboelastography testing the coagulopathy of trauma 1 patients receiving massive amounts of blood products in a ratio previously established by the institutions Standard of Procedure will be evaluated to determine the efficacy of the current blood product ratio.
Interventions
- OTHER Blood collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2013-04 |
| Est. Completion | 2014-12-16 |
What the finished NCT02083549 record still lists
NCT02083549 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Blood collection is the first listed.
NCT02083549 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02083549 about?
NCT02083549 is a clinical study titled "Evaluating URMC's Massive Transfusion Protocol". The purpose of the study is to evaluate the efficacy of the University of Rochester Medical Center's current Massive Transfusion Protocol. Upon arrival of trauma level one designated patients the treating team evaluates the patient's injuries. If the patient is initiated under the facilities Massiv...
What is the current status of trial NCT02083549?
This trial is currently completed. The enrollment target is 2 participants. The study started on 2013-04. Estimated completion is 2014-12-16.
What interventions are being tested in trial NCT02083549?
The interventions under investigation include: Blood collection (OTHER).
Who is sponsoring clinical trial NCT02083549?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia